O
AGN

OrbiMed’s Allergan plc AGN Stock Holding History

OrbiMed’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-957,000
Closed -$128M – 150
2018
Q4 		$128M Sell
957,000
-193,405
-17% -$31.7M 2.37% 10
2018
Q3 		$219M Sell
1,150,405
-135,800
-11% -$24.9M 2.64% 9
2018
Q2 		$214M Buy
1,286,205
+592,600
+85% +$95.1M 2.56% 8
2018
Q1 		$117M Buy
693,605
+406,315
+141% +$68.2M 1.45% 20
2017
Q4 		$47M Sell
287,290
-86,300
-23% -$15.5M 0.59% 48
2017
Q3 		$76.6M Hold
373,590
– – 0.73% 39
2017
Q2 		$90.8M Sell
373,590
-103,800
-22% -$24.4M 0.95% 33
2017
Q1 		$114M Sell
477,390
-292,300
-38% -$68.1M 1.29% 25
2016
Q4 		$162M Sell
769,690
-9,000
-1% -$1.86M 2.06% 15
2016
Q3 		$179M Sell
778,690
-565,925
-42% -$138M 2.04% 11
2016
Q2 		$311M Sell
1,344,615
-228,100
-15% -$52.6M 3.24% 8
2016
Q1 		$422M Buy
1,572,715
+148,000
+10% +$42.4M 4.44% 6
2015
Q4 		$445M Sell
1,424,715
-18,600
-1% -$5.54M 4.03% 4
2015
Q3 		$392M Sell
1,443,315
-68,000
-4% -$20.9M 3.96% 5
2015
Q2 		$459M Sell
1,511,315
-66,872
-4% -$19.9M 3.83% 3
2015
Q1 		$470M Buy
1,578,187
+89,987
+6% +$25.7M 4.01% 4
2014
Q4 		$383M Buy
1,488,200
+52,000
+4% +$13M 3.66% 6
2014
Q3 		$347M Buy
1,436,200
+904,200
+170% +$202M 3.62% 6
2014
Q2 		$119M Buy
532,000
+37,000
+7% +$7.66M 1.39% 30
2014
Q1 		$102M Sell
495,000
-218,000
-31% -$43.2M 1.25% 26
2013
Q4 		$120M Buy
713,000
+237,900
+50% +$37.2M 1.76% 17
2013
Q3 		$68.4M Sell
475,100
-178,100
-27% -$23.7M 1.22% 26
2013
Q2 		$82.4M Buy
+653,200
New +$74M 1.75% 20

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed's AGN Position: Q1 2019 in Review

OrbiMed sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 957,000 shares — an estimated $128M sold.

OrbiMed first reported a position in AGN in Q2 2013 and held it in 23 quarters. The position peaked at $470M in Q1 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • OrbiMed reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • OrbiMed sold 957,000 Allergan plc shares in Q1 2019, an estimated $128M.
  • OrbiMed first reported a position in Allergan plc in Q2 2013 and held it in 23 quarters.
  • OrbiMed's Allergan plc position peaked at $470M in Q1 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.